NO20052568D0 - Fremgangsmate for fremstilling av makrolidforbindelse - Google Patents
Fremgangsmate for fremstilling av makrolidforbindelseInfo
- Publication number
- NO20052568D0 NO20052568D0 NO20052568A NO20052568A NO20052568D0 NO 20052568 D0 NO20052568 D0 NO 20052568D0 NO 20052568 A NO20052568 A NO 20052568A NO 20052568 A NO20052568 A NO 20052568A NO 20052568 D0 NO20052568 D0 NO 20052568D0
- Authority
- NO
- Norway
- Prior art keywords
- macrolide compound
- preparing macrolide
- preparing
- compound
- macrolide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002346796 | 2002-11-29 | ||
| PCT/JP2003/015170 WO2004050890A1 (ja) | 2002-11-29 | 2003-11-27 | マクロライド系化合物の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052568D0 true NO20052568D0 (no) | 2005-05-27 |
| NO20052568L NO20052568L (no) | 2005-06-29 |
Family
ID=32462862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052568A NO20052568L (no) | 2002-11-29 | 2005-05-27 | Fremgangsmate for fremstilling av makrolidforbindelse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7745198B2 (no) |
| EP (1) | EP1580278A4 (no) |
| JP (1) | JP4439401B2 (no) |
| KR (1) | KR20050086873A (no) |
| CN (1) | CN1717493A (no) |
| AU (1) | AU2003284469B2 (no) |
| BR (1) | BR0316746A (no) |
| CA (1) | CA2507641A1 (no) |
| MX (1) | MXPA05005672A (no) |
| NO (1) | NO20052568L (no) |
| NZ (1) | NZ540103A (no) |
| RU (1) | RU2330069C2 (no) |
| WO (1) | WO2004050890A1 (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI334866B (en) * | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| KR20060110865A (ko) | 2003-11-27 | 2006-10-25 | 에자이 가부시키가이샤 | 매크로라이드계 화합물의 수산화에 관여하는 ｄｎａ |
| JP4599357B2 (ja) * | 2004-07-20 | 2010-12-15 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | プラジエノライドの生合成に関与するポリペプチドをコードするｄｎａ |
| TW200716744A (en) * | 2005-05-26 | 2007-05-01 | Eisai R&D Man Co Ltd | Genetically modified microorganism and process for production of macrolide compound using the microorganism |
| WO2007043621A1 (ja) * | 2005-10-13 | 2007-04-19 | Eisai R & D Management Co., Ltd. | プラジエノライド ｂ及びプラジエノライド ｄの全合成方法 |
| AU2007285215A1 (en) * | 2006-08-14 | 2008-02-21 | Eisai R & D Management Co., Ltd. | Stable lyophilized preparation |
| MX2009008068A (es) * | 2007-01-29 | 2009-11-18 | Eisai R&D Man Co Ltd | Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene. |
| JP6437523B2 (ja) | 2013-04-04 | 2018-12-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | マクロライドならびにそれらの調製および使用の方法 |
| AU2015259237B2 (en) | 2014-05-15 | 2019-08-15 | Eisai R&D Management Co., Ltd. | Pladienolide pyridine compounds and methods of use |
| US10633407B2 (en) | 2014-10-08 | 2020-04-28 | President And Fellows Of Harvard College | 14-membered ketolides and methods of their preparation and use |
| EP3273969A4 (en) | 2015-03-25 | 2018-11-21 | President and Fellows of Harvard College | Macrolides with modified desosamine sugars and uses thereof |
| ES2887201T3 (es) | 2015-09-01 | 2021-12-22 | Eisai R&D Man Co Ltd | Variantes de empalme asociadas con mutantes neomórficos de SF3B1 |
| MX379655B (es) | 2015-11-18 | 2025-03-11 | Eisai R&D Man Co Ltd | Una forma en estado solido de compuestos de pladienolida piridina y metodos de uso. |
| AU2018235940A1 (en) | 2017-03-15 | 2019-10-17 | Eisai R&D Management Co., Ltd. | Spliceosome mutations and uses thereof |
| KR20200083532A (ko) | 2017-10-31 | 2020-07-08 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 적어도 1종의 스플라이세오솜 조정제, 및 bcl2 억제제, bcl2/bclxl 억제제 및 bclxl 억제제로부터 선택된 적어도 1종의 억제제를 포함하는 조합물 및 사용 방법 |
| TWI878153B (zh) | 2018-04-09 | 2025-03-21 | 日商衛材R&D企管股份有限公司 | 特定普拉二烯內酯化合物及其使用方法 |
| CN117285502A (zh) | 2018-04-12 | 2023-12-26 | 卫材R&D管理有限公司 | 作为用于治疗癌症的剪接体靶向剂的普拉二烯内酯衍生物 |
| US11998544B2 (en) | 2018-06-01 | 2024-06-04 | Eisai R&D Management Co., Ltd. | Methods of using splicing modulators |
| TW202233187A (zh) | 2020-11-04 | 2022-09-01 | 日商衛材R&D企管股份有限公司 | 骨髓發育不良症候群（ｍｄｓ）之生物標記物及其使用方法 |
| CN114478257A (zh) * | 2021-12-29 | 2022-05-13 | 福建省山河药业有限公司 | 一种抗肿瘤霉菌酸类化合物及其制备方法、应用 |
| WO2023131866A1 (en) | 2022-01-05 | 2023-07-13 | Eisai R&D Management Co., Ltd. | Biomarkers for myelodysplastic syndrome (mds) and methods of using the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04352783A (ja) * | 1991-05-27 | 1992-12-07 | Taisho Pharmaceut Co Ltd | １２員環マクロライド系化合物 |
| WO2000075126A1 (en) | 1999-06-03 | 2000-12-14 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Mycolactone and related compounds, compositions and methods of use |
| US6562602B2 (en) | 2000-08-03 | 2003-05-13 | Kosan Biosciences, Inc. | Fermentation and purification of mycolactones |
| TWI312681B (en) | 2001-02-01 | 2009-08-01 | Novel physiologically active substance | |
| TWI233361B (en) | 2001-04-13 | 2005-06-01 | Gen Hospital Corp | Methods of preventing UVB-induced skin damage |
| TWI334866B (en) | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| WO2004011661A1 (ja) * | 2002-07-31 | 2004-02-05 | Mercian Corporation | 新規生理活性物質 |
| WO2007043621A1 (ja) | 2005-10-13 | 2007-04-19 | Eisai R & D Management Co., Ltd. | プラジエノライド ｂ及びプラジエノライド ｄの全合成方法 |
-
2003
- 2003-11-27 NZ NZ540103A patent/NZ540103A/en unknown
- 2003-11-27 KR KR1020057009524A patent/KR20050086873A/ko not_active Ceased
- 2003-11-27 CN CNA2003801044327A patent/CN1717493A/zh active Pending
- 2003-11-27 CA CA002507641A patent/CA2507641A1/en not_active Abandoned
- 2003-11-27 US US10/532,412 patent/US7745198B2/en not_active Expired - Fee Related
- 2003-11-27 JP JP2004556846A patent/JP4439401B2/ja not_active Expired - Fee Related
- 2003-11-27 WO PCT/JP2003/015170 patent/WO2004050890A1/ja not_active Ceased
- 2003-11-27 RU RU2005120390/13A patent/RU2330069C2/ru not_active IP Right Cessation
- 2003-11-27 BR BR0316746-1A patent/BR0316746A/pt not_active IP Right Cessation
- 2003-11-27 MX MXPA05005672A patent/MXPA05005672A/es active IP Right Grant
- 2003-11-27 AU AU2003284469A patent/AU2003284469B2/en not_active Ceased
- 2003-11-27 EP EP03775924A patent/EP1580278A4/en not_active Withdrawn
-
2005
- 2005-05-27 NO NO20052568A patent/NO20052568L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4439401B2 (ja) | 2010-03-24 |
| MXPA05005672A (es) | 2005-08-16 |
| AU2003284469A1 (en) | 2004-06-23 |
| EP1580278A4 (en) | 2010-08-25 |
| NO20052568L (no) | 2005-06-29 |
| US20060141589A1 (en) | 2006-06-29 |
| JPWO2004050890A1 (ja) | 2006-03-30 |
| RU2330069C2 (ru) | 2008-07-27 |
| EP1580278A1 (en) | 2005-09-28 |
| AU2003284469B2 (en) | 2008-02-21 |
| NZ540103A (en) | 2007-05-31 |
| RU2005120390A (ru) | 2006-01-27 |
| CN1717493A (zh) | 2006-01-04 |
| KR20050086873A (ko) | 2005-08-30 |
| CA2507641A1 (en) | 2004-06-17 |
| US7745198B2 (en) | 2010-06-29 |
| WO2004050890A1 (ja) | 2004-06-17 |
| BR0316746A (pt) | 2005-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033579L (no) | Fremgangsmåte for syntetisering av camptothecin relaterte forbindelser | |
| TWI371438B (en) | Process for producing an organic compound | |
| DE602004019373D1 (de) | Bilderzeugungsverfahren | |
| NO20034969D0 (no) | Fremgangsmåte for fremstilling av olefiner | |
| ATE549329T1 (de) | Chinazoline verbindungen | |
| NO20033887D0 (no) | Fremgangsmåte for fremstilling av stöpestykker | |
| NO20043586L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| TWI372754B (en) | Process for organic compounds | |
| FI991606L (fi) | Menetelmä orgaanisten yhdisteiden valmistamiseksi | |
| EP1664117A4 (en) | IMMUNOGENIC | |
| NO20041182L (no) | Fremgangsmate for fremstilling av silisium | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20052158L (no) | Fremgangsmate for fremstilling av en benzimidazolforbindelse. | |
| EP1598389A4 (en) | METHOD FOR PRODUCING A CATIONICALLY HARDENABLE SILICONE COMPOUND | |
| NO20044447L (no) | Fremgangsmate for fremstilling av metylformiat | |
| NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
| NO20043760L (no) | Fremgangsmate til fremstilling av olefiner | |
| FI20030380L (fi) | Menetelmä prosessin säätämiseksi | |
| ATE359703T1 (de) | Aquakulturverfahren | |
| NO20054907D0 (no) | System for produksjon av sukker | |
| NO20054111D0 (no) | Fremgangsmate for fremtilling av tibolon | |
| EP1539703A4 (en) | METHOD FOR SELECTIVELY PREPARING A 3-OXO-4-AZA-5A ANDROSTAN COMPOUND | |
| EP1670503A4 (en) | IMMUNOTHERAPY METHOD | |
| FI20020163L (fi) | Menetelmä selluloosakarbamaatin valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |